Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-004485-28Phase 3Completed
Phase 3 trial of sodium chloride and lactated ringer's solution in cardiac morbidity (2 arms), sponsored by CHU Grenoble Alpes. Primary endpoint: Change in right ventricular ejection fraction. Started Dec 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-004485-28.